APA (7e ed.) Bronvermelding

Cummings, J., Zweifel, M., Smith, N., Ross, P., Peters, J., Rustin, G., . . . Dive, C. (2012). Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.

Chicago (17e ed.) Bronvermelding

Cummings, J., et al. Evaluation of Cell Death Mechanisms Induced by the Vascular Disrupting Agent OXi4503 During a Phase I Clinical Trial. 2012.

MLA (9e ed.) Bronvermelding

Cummings, J., et al. Evaluation of Cell Death Mechanisms Induced by the Vascular Disrupting Agent OXi4503 During a Phase I Clinical Trial. 2012.